Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.58 |
| ▸ | NPC1 | O15118 | 2/20 | 0.58 |
| ▸ | RAB9A | P51151 | 2/20 | 0.58 |
| ▸ | GRIN2B | Q13224 | 13/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | FAAH | O00519 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34466792 | 0.93 | SMN1; SMN2 (0.56) | SMN1; SMN2NPC1RAB9AGRIN2BCYP2C19 | |
| SCHEMBL25202798 | 0.85 | SMN1; SMN2 (0.55) | SMN1; SMN2NPC1RAB9AGRIN2BCYP2C19 | |
| SCHEMBL2858459 | 0.81 | SMN1; SMN2 (0.61) | SMN1; SMN2NPC1RAB9AGRIN2BCYP2C19 | |
| SCHEMBL25305267 | 0.81 | SMN1; SMN2 (0.61) | SMN1; SMN2NPC1RAB9AGRIN2BCYP2C19 | |
| SCHEMBL4203844 | 0.80 | SMN1; SMN2 (0.70) | SMN1; SMN2NPC1RAB9AGRIN2BCYP2C19 | |
| SCHEMBL29671511 | 0.79 | SMN1; SMN2 (0.65) | SMN1; SMN2NPC1RAB9AGRIN2BCYP2C19 | |
| SCHEMBL25602786 | 0.79 | SMN1; SMN2 (0.61) | SMN1; SMN2NPC1RAB9AGRIN2BCYP2C19 | |
| SCHEMBL15140566 | 0.79 | SMN1; SMN2 (0.72) | SMN1; SMN2NPC1RAB9AGRIN2BCYP2C19 | |
| SCHEMBL458805 | 0.79 | SMN1; SMN2 (0.72) | SMN1; SMN2NPC1RAB9AGRIN2BCYP2C19 | |
| SCHEMBL13661587 | 0.78 | SMN1; SMN2 (0.64) | SMN1; SMN2NPC1RAB9AGRIN2BCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009078992-A1 | LINEAR TRICYCLIC COMPOUNDS AS P38 KINASE INHIBITORS | AMGEN INC. (US) | 2009-06-25 | — | — | WO | disclosed |